Clinical Trial Update: Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the effect of vildagliptin on fat and muscle metabolism in patients with type 2 diabetes; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED